tirzepatide fda approval confirms shortage is still over, gives compounders a grace period Joi + Blokes Zepbound 2026:

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for specific indications: Ozempic and Rybelsus for type 2 diabetes management, and Wegovy for chronic weight management

Breast milk, often termed as liquid gold, is a dynamic and complex fluid, rich in nutrients, antibodies, enzymes, and hormones essential for infant growth and development

Semaglutide (Wegovy) typically costs between 200-300 monthly when purchased through private clinics or online prescription services, whilst liraglutide (Saxenda) generally ranges from 150-250 per month

Rather than guessing whether tirzepatide is the right compound for you, genetic insight reveals whether your FTO, MC4R, or GLP1R variants align better with single-agent semaglutide, a higher tirzepatide dose, or even a dual-action compound like GLP-Squared

Experts say semaglutide offers disease-modifying benefits